The data presented in this study indicate that urinary hemopexin may differentiate active LN from inactive LN regardless of patient demographics (p < 0.05, Mann–Whitney U-test; AUC > 0.7), but its potential use among Caucasian patients may be limited due to high background levels even among healthy individuals. Here, HPX is linked to lobular neoplasia.